Evidence map›Paper›PMID 27217562›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Aurora kinase-induced phosphorylation excludes transcription factor RUNX from the chromatin to facilitate proper mitotic progression.

Linda Shyue Huey Chuang, Jian Ming Khor, Soak Kuan Lai, Shubham Garg, Vaidehi Krishnan, Cheng-Gee Koh, Sang Hyun Lee, Yoshiaki Ito

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. OTUD6A Is an Aurora Kinase A-Specific Deubiquitinase.International journal of molecular sciences · 2021
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Aurora kinase and RUNX: Reaching beyond transcription.Cell cycle (Georgetown, Tex.) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Linda Shyue Huey ChuangCancer Science Institute of Singapore, National University of Singapore, Singapore 117599;
Jian Ming KhorCancer Science Institute of Singapore, National University of Singapore, Singapore 117599;
Soak Kuan LaiSchool of Biological Sciences, Nanyang Technological University, Singapore 637551;
Shubham GargCancer Science Institute of Singapore, National University of Singapore, Singapore 117599;
Vaidehi KrishnanCancer Science Institute of Singapore, National University of Singapore, Singapore 117599;
Cheng-Gee KohSchool of Biological Sciences, Nanyang Technological University, Singapore 637551;
Sang Hyun LeeProgram in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore 169857.
Yoshiaki ItoCancer Science Institute of Singapore, National University of Singapore, Singapore 117599; csiitoy@nus.edu.sg.
National University of Singapore · SGNanyang Technological University · SGDuke-NUS Medical School · SGNational University Cancer Institute, Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Runt-related transcription factors (RUNX) are master regulators of development and major players in tumorigenesis. Interestingly, unlike most transcription factors, RUNX proteins are detected on the mitotic chromatin and apparatus, suggesting that they are functionally active in mitosis. Here, we identify key sites of RUNX phosphorylation in mitosis. We show that the phosphorylation of threonine 173 (T173) residue within the Runt domain of RUNX3 disrupts RUNX DNA binding activity during mitotic entry to facilitate the recruitment of RUNX proteins to mitotic structures. Moreover, knockdown of RUNX3 delays mitotic entry. RUNX3 phosphorylation is therefore a regulatory mechanism for mitotic entry. Cancer-associated mutations of RUNX3 T173 and its equivalent in RUNX1 further corroborate the role of RUNX phosphorylation in regulating proper mitotic progression and genomic integrity.

Indexed as

AnimalsAurora KinasesChlorocebus aethiopsChromatinCore Binding Factor Alpha 3 SubunitCore Binding Factor alpha SubunitsCOS CellsDNAGene Knockdown TechniquesHEK293 CellsHumansMitosisMutationPhosphorylationRecombinant ProteinsThreonineAurora KinasesChromatinCore Binding Factor Alpha 3 SubunitCore Binding Factor alpha SubunitsDNARecombinant ProteinsRunx3 protein, humanThreonineAurora kinasecentrosomemitosisphosphorylationRUNX

Identifiers

PMID27217562
PMCPMC4988568
OpenAlexW2400616287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.